A top US lawyer recently spoke at a conference in Washington where he placed focus on four cases for the Supreme Court, two antitrust and two patent cases, as the most important business cases this term. The top advocate for the Supreme Court under the Obama administration, solicitor General Donald Verrilli, made his remarks at an event at Georgetown Law Center. Perhaps most notable is his comment that the Federal Trade Commission, in a way, “won” in the Supreme Court in the court’s unanimous decision in FTC vs. Phoebe Putney Health System; decided last February, the Court ruled that the local hospital authority was not immune to federal antitrust law. Verrilli also mentioned the current FTC vs. Actavis course, which will be argued on March 25 concerning pay-for-delay pharmaceutical deals.
Featured News
States Move to Rein In Crypto Kiosks as Fraud Concerns Mount
Apr 29, 2026 by
CPI
Italian Drugmaker to Buy KalVista for $1.9 Billion
Apr 29, 2026 by
CPI
France Flags Systemic Rule Violations in Online Marketplaces Amid EU Crackdown
Apr 29, 2026 by
CPI
NCAA Agrees to End Prize Money Restrictions in Settlement with Tennis Players
Apr 29, 2026 by
CPI
South Korea Regulator’s Move on Coupang Founder Triggers Planned Lawsuit
Apr 29, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Unilateral Effects
Apr 28, 2026 by
CPI
A Net Present Value Approach to Merger Analysis
Apr 28, 2026 by
Joseph J Simons & Malcolm Coate
Generative AI and Competitive Disruption: Increasingly Relevant for Merger Analysis?
Apr 28, 2026 by
Andrea Coscelli, Emily Chissell, Nitika Bagaria & Tega Akati-Udi
Non-Price Unilateral Effects In Media Mergers
Apr 28, 2026 by
Lapo Filistrucchi & Teresa Oriani
Ecosystem Mergers and Unilateral Effects? A Framework for Assessing the Ecosystem Theory of Harm
Apr 28, 2026 by
Ethel Fonseca, George Tucker & Helder Vasconcelos